Medex Inc. Warns Public Of Un-Solicited Email Spam

CHULA VISTA, Calif., Jan. 16, 2013 /PRNewswire/ -- Medex Inc. (OTC Markets Group, Inc.: MDXX) announces today that the Company and its officers wish to warn the public regarding the unauthorized and unsolicited use of company press releases, corporate website domain and information relating to the Company by an unknown party and that such use is illegal spam and strictly prohibited.  Medex Inc. is currently investigating the source of this illegal spam with the assistance of its corporate counsel.  Medex Inc. expressly prohibits the use of spam and demands that the responsible party immediately cease this illegal activity.

Medex Inc. encourages the public to be well informed and to thoroughly research any investment of securities prior to making any financial commitment as well as seek the advice of a licensed broker prior to investing. The Company further cautions the public against relying upon unsolicited emails or phone calls when it comes to investing. Medex Inc. is currently investigating the source of this illegal spam with the assistance of its corporate counsel.

The Company deeply regrets the inconvenience this has caused and apologizes to those whom have been affected.  Medex Inc. has not given any authorization, express or implied, for any company or persons to perform in this manner.  These actions qualify as stock promotion and are classified as illegal marketing tactics.

About Medex Inc.

Medex, Inc. is publicly traded on the OTC Markets Group (MDXX) and is a California based medical support and services Company.  It distributes quality Medicare – Accredited medical equipment and supplies to consumers, medical professionals and insurance carriers.   The Company's vision is to be a pre-eminent medical and equipment supply Company by providing products for people with disabilities, recovering from surgery, in rehabilitation facilities, nursing homes, assisted living centers and the elderly.  For additional information please visit the company's website at http://www.21stsynergymedical.com.

Contact: Investor Relations:1-800-245-7791 Ext. #3 Email: [e-mail]: www.21stsynergymedical.com

Safe Harbour Statement

1 2 Next › Last »